NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
+24.51%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.93B
AUM Growth
+$1.93B
(-24%)
Cap. Flow
-$840M
Cap. Flow
% of AUM
-43.59%
Top 10 Holdings %
Top 10 Hldgs %
67.29%
Holding
46
New
–
Increased
5
Reduced
3
Closed
1
Top Buys
| 1 |
Mersana Therapeutics
MRSN
|
$19.7M |
| 2 |
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
|
$12.7M |
| 3 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
$5.87M |
| 4 |
Aurinia Pharmaceuticals
AUPH
|
$2.37M |
| 5 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$561K |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$774M |
| 2 |
Elastic
ESTC
|
$63.2M |
| 3 |
X4 Pharmaceuticals
XFOR
|
$29M |
| 4 |
ELGX
Endologix Inc
ELGX
|
$14.8M |
Sector Composition
| 1 | Healthcare | 69.08% |
| 2 | Technology | 27.53% |
| 3 | Industrials | 0.63% |
